Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
Arthritis Care & Research|October 11, 2014
Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort studyRishi J Desai, Wesley Eddings, Katherine P Liao, et al.
Acta Diabetologica|October 15, 2014
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort studySeoyoung C Kim, Robert J Glynn, Jun Liu, et al.
Arthritis Research & Therapy|April 17, 2015
An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity scoreRishi J Desai, Daniel H Solomon, Michael E Weinblatt, et al.
Gut|April 7, 2022
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's diseaseJulien Kirchgesner, Rishi J Desai, Maria C Schneeweiss, et al.
JAMA Internal Medicine|February 6, 2023
Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c LevelsElvira D'Andrea, Deborah J Wexler, Seoyoung C Kim, et al.
Seminars in Arthritis and Rheumatism|November 13, 2022
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosusMia T Chandler, Leah M Santacroce, Karen H Costenbader, et al.
BMJ (Clinical Research Ed.)|August 27, 2020
Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort studyMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
The Journal of Rheumatology|December 3, 2019
Risk of Diabetes Mellitus in Patients with Juvenile Idiopathic ArthritisHemin Lee, Yinzhu Jin, Jun Liu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 29, 2017
Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort studyRishi J Desai, Joshua J Gagne, Joyce Lii, et al.
The American Journal of Medicine|February 10, 2015
Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort studySeoyoung C Kim, Sebastian Schneeweiss, Niteesh Choudhry, et al.
Pageof 19